Note 10 - Warrants to Purchase Common Stock |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Outstanding Warrants [Text Block] |
10. Warrants to Purchase Common Stock
On December 31, 2025, the maturity dates on two accredited investors Subordinated Notes were extended to June 30, 2026. In connection with the extension, the Company issued warrants exercisable for the purchase of 113 thousand shares of Aemetis, Inc. common stock with a year term and an exercise price of $0.01 per share. The warrants were fully exercised by the noteholders in January 2026. On June 30, 2026, the maturity dates of the Subordinated Notes were further extended to December 31, 2026, and the Company issued an additional 113 thousand warrants with the same terms. The warrants were fully exercised by the noteholders in July 2026.
The following table summarizes warrant activity during the nine months ended September 30, 2026:
All of the above outstanding warrants are fully vested and exercisable as of September 30, 2026.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||